VACCHI, CATERINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.990
EU - Europa 6.929
AS - Asia 3.913
SA - Sud America 628
Continente sconosciuto - Info sul continente non disponibili 192
AF - Africa 136
OC - Oceania 86
Totale 19.874
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.610
IT - Italia 4.323
SG - Singapore 1.157
CN - Cina 864
GB - Regno Unito 656
SE - Svezia 440
BR - Brasile 434
HK - Hong Kong 382
VN - Vietnam 360
DE - Germania 280
CA - Canada 228
BD - Bangladesh 225
FR - Francia 222
RU - Federazione Russa 206
FI - Finlandia 181
IN - India 159
NL - Olanda 155
TR - Turchia 141
JP - Giappone 139
KR - Corea 117
ID - Indonesia 97
UA - Ucraina 86
AU - Australia 78
MX - Messico 76
IE - Irlanda 67
AR - Argentina 63
BG - Bulgaria 59
PK - Pakistan 48
TN - Tunisia 47
PL - Polonia 43
EC - Ecuador 39
IQ - Iraq 35
MY - Malesia 33
ZA - Sudafrica 30
ES - Italia 27
LT - Lituania 26
CO - Colombia 22
CL - Cile 20
PE - Perù 20
AT - Austria 19
AE - Emirati Arabi Uniti 17
EG - Egitto 16
IR - Iran 16
SA - Arabia Saudita 16
JO - Giordania 15
VE - Venezuela 15
CR - Costa Rica 14
BE - Belgio 13
HU - Ungheria 13
PT - Portogallo 13
DK - Danimarca 12
CH - Svizzera 11
PH - Filippine 11
TH - Thailandia 11
KE - Kenya 10
RO - Romania 10
DZ - Algeria 9
IL - Israele 9
NP - Nepal 9
OM - Oman 9
RS - Serbia 9
BZ - Belize 8
CZ - Repubblica Ceca 8
LU - Lussemburgo 8
MA - Marocco 8
NZ - Nuova Zelanda 8
PY - Paraguay 8
TW - Taiwan 8
EE - Estonia 7
HN - Honduras 7
JM - Giamaica 7
UZ - Uzbekistan 7
HR - Croazia 6
SV - El Salvador 6
BO - Bolivia 5
GT - Guatemala 5
NI - Nicaragua 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
BY - Bielorussia 4
CY - Cipro 4
GR - Grecia 4
MD - Moldavia 4
PR - Porto Rico 4
AL - Albania 3
BB - Barbados 3
DO - Repubblica Dominicana 3
LV - Lettonia 3
PA - Panama 3
PS - Palestinian Territory 3
SY - Repubblica araba siriana 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
BH - Bahrain 2
BS - Bahamas 2
ET - Etiopia 2
EU - Europa 2
GY - Guiana 2
KG - Kirghizistan 2
KW - Kuwait 2
Totale 19.651
Salva come PNG Salva come JPEG
Città #
Ashburn 868
Singapore 780
Santa Clara 766
Fairfield 591
San Jose 437
Chandler 419
Hong Kong 365
Milan 341
Council Bluffs 321
Rome 309
Southend 285
Woodbridge 262
Nyköping 245
Houston 207
Hefei 183
Seattle 177
Wilmington 176
Beijing 172
London 167
Cambridge 163
New York 163
Los Angeles 161
Helsinki 155
Ann Arbor 141
The Dalles 121
Chicago 112
Bologna 103
Ho Chi Minh City 91
Seoul 88
Hanoi 87
Naples 85
Florence 74
San Diego 73
Jacksonville 70
Toronto 70
Modena 69
Jakarta 67
Bari 62
Catania 59
Dallas 59
Shanghai 58
Sofia 57
Dearborn 55
Palermo 53
Buffalo 52
Dublin 52
Redwood City 52
Tokyo 52
Princeton 50
Bremen 49
Moscow 47
Perth 47
Frankfurt am Main 44
São Paulo 44
Turin 44
Lauterbourg 42
Munich 41
Salt Lake City 39
Verona 39
Columbus 37
Genoa 37
North York 37
Orem 36
Atlanta 33
Cagliari 33
Izmir 30
Eugene 27
Manchester 27
Chennai 26
Guayaquil 25
Padova 25
Falls Church 24
Mexico City 24
Ankara 23
Istanbul 23
Phoenix 23
Salerno 23
Warsaw 23
Mumbai 22
Parma 22
Da Nang 21
Denver 21
Boardman 20
Brooklyn 20
Reggio Emilia 20
Venice 19
Boston 18
Brescia 18
Rio de Janeiro 18
San Francisco 18
Bergamo 17
Elk Grove Village 17
Tampa 17
Treviso 17
Haiphong 16
Johannesburg 16
Montreal 16
Pisa 16
Santiago 16
Baghdad 15
Totale 10.997
Salva come PNG Salva come JPEG
Nome #
INTERSTIZIOPATIA POLMONARE NON CLASSIFICABILE O SECONDARIA A CONNETTIVITE INDIFFERENZIATA. IMPORTANZA E DIFFICOLTÀ DI UNA DIAGNOSI DIFFERENZIALE. 3.906
Epidemiology and management of interstitial lung disease in ANCA-associated vasculitis 1.415
COVID-19-associated vasculitis and thrombotic complications: from pathological findings to multidisciplinary discussion 536
Radiological thymus alterations in systemic sclerosis: our experience and a review of the literature. 393
Breast cancer in systemic sclerosis: Results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature 389
INTERSTITIAL LUNG DISEASE RELATED TO RHEUMATOID ARTHRITIS. WHAT DO WE DON’T KNOW? THE LIRA STUDY (LUNG INVOLVEMENT IN RHEUMATOID ARTHRITIS) 374
Combination Therapy with Nintedanib and Sarilumab for the Management of Rheumatoid Arthritis Related Interstitial Lung Disease 364
Established coronary artery disease in systemic sclerosis compared to type 2 diabetic female patients: a cross-sectional study 359
Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature 349
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 332
Lung cancer in scleroderma: results from an Italian rheumatologic center and review of the literature. 331
Efficacy and safety of mycophenolate mofetil in the treatment of rheumatic disease-related interstitial lung disease: a narrative review 329
COST ANALYSIS RELATED TO SUBCUTANEOUS IMMUNOGLOBULINS IN PATIENTS WITH INFLAMMATORY MYOPATHIES AND IMMUNE-MEDIATED CHRONIC NEUROPATHIES. RESULTS OF AN OPEN LABEL STUDY 319
Interstitial pneumonia with autoimmune features: A single center prospective follow-up study 315
Safety of Abatacept in Italian Patients with Rheumatoid Arthritis and Interstitial Lung Disease: A Multicenter Retrospective Study 314
CLINICAL AND PATHOLOGICAL FEATURES OF BREAST CANCER IN PATIENTS WITH SYSTEMIC SCLEROSIS: PRELIMINARY DATA FROM THE SCLERO-BREAST STUDY 310
Interstitial pneumonia with autoimmune features and undifferentiated connective tissue disease: Our interdisciplinary rheumatology-pneumology experience, and review of the literature 307
Haematological Malignancies in Systemic Sclerosis Patients: Case Reports and Review of the World Literature 302
AB1157 VALIDATION OF VECTOR (VELCRO CRACKLES DETECTOR) FOR THE DIAGNOSIS OF INTERSTITIAL LUNG DISEASE IN PATIENTS WITH CONNECTIVE TISSUE DISEASES 297
PREVALENZA, CORRELATI CLINICO-SEROLOGICI E CARATTERISTICHE RADIOLOGICHE DELL'INTERSTIZIOPATIA POLMONARE IN UN'AMPIA COORTE DI PAZIENTI AFFETTI DA SINDROME DI SJOGREN 296
UNCLASSIFIABLE INTERSTITIAL LUNG DISEASE OR UNDIFFERENTIATED CONNECTIVE TISSUE DISEASE? A CHALLENGING DIFFERENTIAL DIAGNOSIS 290
Classification of pulmonary sounds through deep learning for the diagnosis of interstitial lung diseases secondary to connective tissue diseases 272
Therapeutic Options for the Treatment of Interstitial Lung Disease Related to Connective Tissue Diseases. A Narrative Review 270
Clinical and Pathological Features of Breast Cancer in Systemic Sclerosis: Results from the Sclero-Breast Study 268
RHEUMATOID ARTHRITIS RELATED INTERSTITIAL LUNG DISEASE. RADIOLOGICAL PATTERNS AND CORRELATIONS WITH CLINICAL, SEROLOGICAL AND DEMOGRAPHIC FEATURES OF DISEASE 259
AB0624 SAFETY OF RITUXIMAB BIOSIMILAR FOR THE TREATMENT OF CRYOGLOBULINEMIC VASCULITIS 250
AB0472 PRIMARY SJOGREN SYNDROME ASSOCIATED INTERSTITIAL LUNG DISEASE: FEATURES, TREATMENT AND OUTCOME OF A MONOCENTRIC COHORT 249
COVID-19 vaccination rate and safety profile in a multicentre Italian population affected by mixed cryoglobulinaemic vasculitis 248
Procedural pain management in the treatment of scleroderma digital ulcers 248
Efficacy and safety of rituximab in the treatment of connective tissue disease-related interstitial lung disease 242
PAP-TEST FEATURES IN A COHORT OF SYSTEMIC SCLEROSIS PATIENTS 236
Erratum: Acute exacerbation of interstitial lung diseases secondary to systemic rheumatic diseases: A prospective study and review of the literature (Journal of Thoracic Disease (2019) 11 (1621-1628) DOI: 10.21037/jtd.2019.03.28) 228
Molecular Pathways of Breast Cancer in Systemic Sclerosis: Exploratory Immunohistochemical Analysis from the Sclero-Breast Study 227
Tofacitinib for the Treatment of Severe Interstitial Lung Disease Related to Rheumatoid Arthritis 224
CHARACTERIZATION OF ANTI-MPO POSITIVE INTERSTITIAL LUNG DISEASE. CLINICAL-SEROLOGIC AND RADIOLOGIC FEATURES AND SURVIVAL 221
VECTOR: An algorithm for the detection of COVID-19 pneumonia from velcro-like lung sounds 220
Usefulness of digital velcro crackles detection in identification of interstitial lung disease in patients with connective tissue diseases 219
FRI0613 THERAPEUTIC STRATEGIES AND SURVIVAL IN PATIENTS WITH INTERSTITIAL PNEUMONIA WITH AUTOIMMUNE FEATURES 211
Safety and effectiveness of biosimilar of Rituximab CT-P10 in the treatment of cryoglobulinemic vasculitis: the MARBLe study (Mixed cryoglobulinemiA Rituximab BiosimiLar) 209
Pirfenidone for the treatment of interstitial lung disease associated to rheumatoid arthritis: a new scenario is coming? 208
Vasculitis in a patient with mixed cryoglobulinemia treated with rituximab biosimilar CT-P10: a case report 205
Treatment of Rheumatoid Arthritis-Associated Interstitial Lung Disease: Lights and Shadows 203
Fibrosing interstitial lung disease in primary Sjogren syndrome 196
Diagnosis, Clinical Features and Management of Interstitial Lung Diseases in Rheumatic Disorders: Still a Long Journey 196
THU0289 PERSISTENCE OF CIRCULATING CRYOGLOBULINS AND RELATED SYMPTOMS AFTER HEPATITIS C VIRUS ERADICATION IN PATIENTS WITH MIXED CRYOGLOBULIN SYNDROME 191
Interstitial pneumonia with autoimmune features: Why rheumatologist–pulmonologist collaboration is essential 190
ACCERTAMENTO DELLA DISABILITÀ NELLE MALATTIE REUMATOLOGICHE (EX L.R. N.4 DEL 19 FEBBRAIO 2008) PROPOSTA DI PROTOCOLLO ORGANIZZATIVO 183
Pathogenesis and treatment of idiopathic and rheumatoid arthritis-related interstitial pneumonia. The possible lesson from COVID-19 pneumonia 167
Pneumopathie interstitielle fibrosante dans le syndrome de Gougerot-Sjögren primitif 167
Erratum: Unusual association between Budd-Chiari syndrome secondary to antiphospholipid syndrome and relapsing polychondritis: A case report and review of the literature (Clinical Rheumatology (2013) 32 (905-907) DOI: 10.1007/s10067-013-2229-z) 161
Fibrosing Progressive Interstitial Lung Disease in Rheumatoid Arthritis: A Multicentre Italian Study 155
Therapeutic Strategies and Survival in Patients with Interstitial Pneumonia with Autoimmune Features 146
COVID-19 VACCINATION RATE AND SAFETY PROFILE IN PATIENTS AFFECTED BY MIXED CRYOGLOBULINEMIC VASCULITIS 146
SAT0470 Pap-Test Features in a Cohort of Systemic Sclerosis Patients 142
Reply to “ Sjögren's syndrome and pulmonary hypertension: Correspondence” 138
Sjögren's syndrome and pulmonary hypertension: Exploring the intricate link with interstitial lung disease 134
Rheumatoid arthritis extra-articular lung disease: new insights on pathogenesis and experimental drugs 133
POS1053 PREVALENCE OF FIBROSING PROGRESSIVE INTERSTITIAL LUNG DISEASE IN RHEUMATOID ARTHRITIS PATIENTS 131
Reply to “Considerations on Patient Age in the Study of Pulmonary Hypertension and Interstitial Lung Disease in Sjögren's Syndrome” 103
PROPOSAL OF CORE OUTCOME DOMAINS IN MIXED CRYOGLOBULINEMIC VASCULITIS 101
Real-World Use of Anifrolumab for Articular Involvement in Systemic Lupus Erythematosus: A Monocentric Case Series and Systematic Review 85
Hemoglobin-to-Red Cell Distribution Width Ratio and Vitamin D Status as Early Predictors of Cardiovascular Risk in Primary Sjögren’s Syndrome 76
Beyond systemic lupus erythematosus: a systematic review on the use of belimumab in other connective tissue diseases and vasculitides 72
Personalized Medicine and Machine Learning: A Roadmap for the Future 71
HCV-related cryoglobulinemic vasculitis (mixed cryoglobulinemia syndrome) in the era of direct-acting antivirals: A 10-year experience from Italian tertiary referral centers 46
Totale 19.874
Salva come PNG Salva come JPEG
Categoria #
all - tutte 68.779
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.779
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.292 0 0 0 92 113 145 87 87 183 118 243 224
2022/20232.350 235 187 153 161 227 208 165 236 240 133 243 162
2023/20242.467 126 138 165 256 275 252 237 348 75 128 215 252
2024/20253.679 187 117 159 260 589 499 355 227 376 153 327 430
2025/20265.623 359 201 413 654 781 415 649 279 574 499 471 328
2026/20271.288 160 342 331 455 0 0 0 0 0 0 0 0
Totale 19.874